Search for Clinical Trials
An extension of studies to evaluate Abbv-951 in subjects with advanced Parkinson's disease (H-52937)
Abbvie Inc. - An Open-label extension of studies M15-736 and M20-339 to evaluate the safety and tolerability of 24-hour daily exposure of Abbv-951 in…
A multicenter, double-blind, placebo-controlled, randomized withdrawal study to evaluate the safety and maintenance of efficacy of ecopipam in…
The purpose of this study is to find out how safe and effective the new drug, AMX0035, is for the treatment of PSP and to determine if AMX0035 can…
A multicenter, open-label, study to evaluate the longterm safety of ecopipam tablets in children, adolescents and adults with Tourette's disorderThe…
IKT-148009-201/ A Phase 2, randomized, double-blind, placebo-controlled trial of IKT-148009 in untreated Parkinson's diseaseThe purpose of this study…
A 17-Week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, multicenter study of the efficacy and safety of…
An open-label study of the long-term safety and tolerability of Sage-324 in participants with essential tremorThe purpose of this study is to…
Sage Therapeutics, Inc. is sponsoring this study of an investigational drug called SAGE-718. SAGE-718 is being evaluated for possible…
The Relight clinical research study is currently testing an investigational medication for people living with depression, or Major Depressive…
Multiple gestation increases the risk of preterm delivery. Babies born preterm have increased rates of neonatal mortality and long-term…
